收藏商品
全国免费服务热线
4000-520-616
PotentLXRagonist(IC50valuesare24and179nMforLXRβandLXRα,respectively).ReducestotalserumcholesterolandLDLcholesterol,andinhibitslesiongrowthinmodelsofatherosclerosis.IncreasesABCA1andABCG1mRNAlevelsinratperipheralbloodcells.Orallybioavailable.
SoldforresearchpurposesunderagreementfromPfizerInc.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight422.78.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
DIBLasio-Smithetal(2008)DiscoveryandimplementationoftranscriptionalbioMarkersofsyntheticLXRagonistsinperipheralbloodcells.J.Transl.Med.6PMID:18925943
Quinetetal(2009)LXRligandlowersLDLcholesterolinprimates,islipidneutralinhamster,andreducesatherosclerosisinmouse.J.LipidRes.502358PMID:19318684
Keywords:WAY252623,supplier,LXR,liver,X,receptor,alpha,beta,LXRa,LXRb,β,α,potent,agonists,agonism,orally,bioavailable,LXR-like,Receptors,LXR-like,Receptors,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10